Chk1 Inhibitors for Novel Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 4, 2006-07 ,pp. : 377-388

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Therapy with Histone Deacetylase Inhibitors and Lithium Chloride: A Novel Treatment for Carcinoid Tumors

By Adler Joel  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite

Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment

By Smalley Keiran SM   Flaherty Keith T  

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 775-778

Future Medicine

Access to resources Recommend Favorite

Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

By Chae Young Kwang   Valsecchi Matias E.   Kim Jongoh   Bianchi Anabella Lucca   Khemasuwan Danai   Desai Ajit   Tester William  

Cancer Investigation, Vol. 29, Iss. 9, 2011-10 ,pp. : 585-593

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors in the treatment of cancer

By Brown Peter  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite